<DOC>
	<DOCNO>NCT02630303</DOCNO>
	<brief_summary>The goal study establish safety high fluence LED-RL 160 J/cm2 640 J/cm2 healthy subject . The hypothesis high fluence LED-RL phototherapy safe human skin .</brief_summary>
	<brief_title>High Fluence Light Emitting Diode-Red Light ( LED-RL ) Human Skin</brief_title>
	<detailed_description>Skin fibrosis involve variety pathologic process range exuberant scar formation secondary surgery trauma , hypertrophic keloid scar , immune-mediated process scleroderma chronic graft-versus-host disease . As highlighted quality-of-life study , skin fibrosis imparts significant socioeconomic burden due functional , aesthetic , psychosocial impact patient 's life . The effect visible light , common environment ( visible spectrum account 44 % total solar energy ) , remain undefined . An important safety feature visible red light ( 600 nm 700 nm ) generate pro-carcinogenic DNA damage ultraviolet ( UV ) light . Recently publish clinical observation indicate red light combination modality photosensitizers combine red light photodynamic therapy lessen skin fibrosis . However , preliminary vitro data generate investigator 's research group suggest red light function stand-alone treatment , eliminate side-effects chemical photosensitizers potential long-term harm current UV therapy . Furthermore , commercially available light emit diode-red light ( LED-RL ) unit exist already FDA-cleared dermatological us ( rhytides acne ) , thus clinical translation use skin fibrosis could occur relatively quickly follow safety efficacy demonstration . Developing high fluence LED-RL phototherapy treatment skin fibrosis would represent important advance scar condition lack serious systemic side effect associate immunomodulatory agent ( oral steroid ) ; avoids need invasive , painful injection anti-fibrotic agent ( intralesional steroid , 5-fluorouracil bleomycin ) ; eliminate UV-induced DNA damage associate skin cancer photoaging associate current UVA/UVA1 UVB/narrowband UVB phototherapy . To investigator research group 's knowledge , clinical trial perform determine safety high fluence LED-RL treatment skin fibrosis . Therefore , innovation approach investigator research group intend study high fluence LED-RL safe modality treatment skin fibrosis .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Keloid</mesh_term>
	<mesh_term>Cicatrix</mesh_term>
	<mesh_term>Coal Tar</mesh_term>
	<criteria>Healthy subject sex , ethnicity age Nondominant proximal anterior forearm wide enough ensure reproducible placement LEDRL phototherapy mock therapy handheld unit Available willing attend clinic visit Able willing give inform consent Subjects use photosensitizers ( i.e . lithium , melatonin , phenothiazine antipsychotic , antibiotic ) Subjects diabetes mellitus ( DM ) Subjects history skin cancer ; basal cell carcinoma ( BCC ) squamous cell carcinoma ( SCC ) . Subjects systemic lupus erythematous ( SLE ) Subjects medical condition could compromise exposure propose treatment Subjects lightsensitive condition photosensitize medication ( All subject test photosensitivity per manufacturer user guide instruction ) Subjects open wound nondominant proximal anterior forearm Subjects fibrotic skin disease skin condition nondominant proximal anterior forearm Subjects tattoo cover procedure site nondominant proximal anterior forearm</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>light emit diode-red light</keyword>
	<keyword>LED-RL</keyword>
	<keyword>high fluence</keyword>
	<keyword>skin fibrosis</keyword>
	<keyword>wound healing</keyword>
	<keyword>scar</keyword>
	<keyword>keloid</keyword>
	<keyword>RCT</keyword>
</DOC>